Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Heart Circ Physiol ; 294(1): H134-44, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17982017

ABSTRACT

The parasympathetic (P) nervous system is thought to contribute significantly to focal atrial fibrillation (AF). Thus we hypothesized that P nerve fibers [and related muscarinic (M(2)) receptors] are preferentially located in the posterior left atrium (PLA) and that selective cholinergic blockade in the PLA can be successfully performed to alter vagal AF substrate. The PLA, pulmonary veins (PVs), and left atrial appendage (LAA) from six dogs were immunostained for sympathetic (S) nerves, P nerves, and M(2) receptors. Epicardial electrophysiological mapping was performed in seven additional dogs. The PLA was the most richly innervated, with nerve bundles containing P and S fibers (0.9 +/- 1, 3.2 +/- 2.5, and 0.17 +/- 0.3/cm(2) in the PV, PLA, and LAA, respectively, P < 0.001); nerve bundles were located in fibrofatty tissue as well as in surrounding myocardium. P fibers predominated over S fibers within bundles (P-to-S ratio = 4.4, 7.2, and 5.8 in PV, PLA, and LAA, respectively). M(2) distribution was also most pronounced in the PLA (17.8 +/- 8.3, 14.3 +/- 7.3, and 14.5 +/- 8 M(2)-stained cells/cm(2) in the PLA, PV, and LAA, respectively, P = 0.012). Left cervical vagal stimulation (VS) caused significant effective refractory period shortening in all regions, with easily inducible AF. Topical application of 1% tropicamide to the PLA significantly attenuated VS-induced effective refractory period shortening in the PLA, PV, and LAA and decreased AF inducibility by 92% (P < 0.001). We conclude that 1) P fibers and M(2) receptors are preferentially located in the PLA, suggesting an important role for this region in creation of vagal AF substrate and 2) targeted P blockade in the PLA is feasible and results in attenuation of vagal responses in the entire left atrium and, consequently, a change in AF substrate.


Subject(s)
Atrial Fibrillation/physiopathology , Pulmonary Veins/innervation , Receptor, Muscarinic M2/metabolism , Sympathetic Nervous System/physiopathology , Vagus Nerve/physiopathology , Action Potentials , Animals , Atrial Appendage/innervation , Atrial Appendage/metabolism , Atrial Fibrillation/metabolism , Atrial Fibrillation/prevention & control , Dogs , Electric Stimulation , Ganglia, Autonomic/metabolism , Ganglia, Autonomic/physiopathology , Heart Atria/innervation , Heart Atria/metabolism , Muscarinic Antagonists/pharmacology , Pulmonary Veins/drug effects , Pulmonary Veins/metabolism , Receptor, Muscarinic M2/antagonists & inhibitors , Research Design , Sympathetic Nervous System/metabolism , Time Factors , Tropicamide/pharmacology , Vagus Nerve/drug effects , Vagus Nerve/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...